KBC Securities - Koninklijke DSM N.V. (DSM) Morning Note: DSM NA

Report

KBC Securities

Wim Hoste

Morning Note: DSM NA

DSM : Completed acquisition of CSK

02/01/2020 5 EN

Underlying

Koninklijke DSM N.V.

Royal DSM is engaged in the creation of products and services in Life Sciences and Materials Sciences. Co.'s products and services are used globally in range of markets and applications in healthcare, pharmaceutical automotive and chemicals sectors. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. The activities of Co. are grouped into four clusters: Nutrition, Pharma, Performance Materials and Polymer Intermediates.

See profile

NL0000009827 Netherlands

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Wim Hoste

Other Reports on these Companies

ING Financial Markets

Benelux Morning Notes

Aalberts: Preview; facing realistic expectations. BAM: Hard hats off! dsm-firmenich AG: Animal Farm(ed out). Econocom: Sales and net profit in line, REBITA margin better, net debt above. Fagron: 2H23 REBITDA beats 2%, driven by US Compounding, marred by sharp EMEA margin drop. Results Calendar

February 15, 2024 February 15, 2024 1 EN

ING Financial Markets

DSM-Firmenich/Vitamin overdose/BUY

We update our forecasts and valuation for dsm-firmenich. Incorporating the impact of restructuring, the vitamin business lowers our 2024F adjusted EBITDA by 23% to €1.9bn. Applying peer Givaudan's Bloomberg consensus 2024F EV/EBITDA multiple to DSM-Firmenich gives us a 12-month fair value of €158 (down from €182). We adjust our target price accordingly and maintain our BUY recommendation.

December 22, 2023 December 22, 2023 1 EN

ING Financial Markets

Benelux Morning Notes

Aalberts: Preview - slowing top line growth. AB InBev: Steady hand. Aedifica: 2023 EPS guidance slightly up, DPS reconfirmed. DSM-Firmenich AG: Vitamin overdose. Mithra Pharmaceuticals: Appointment of new independent directors required. Randstad: Strategic update at capital markets day

October 31, 2023 October 31, 2023 1 EN

Morning Notes : ABN NA, AD NA, HEIA NA, LOTB BB, RAND NA, ALFEN NA, PHVS US

: ABN NA, AD NA, HEIA NA, LOTB BB, RAND NA, ALFEN NA, PHVS US

8h / 46m 8h / 46m 1 EN

Wim Hoste

Wim Hoste

Heineken FIRST LOOK: FY25 operating profit +4.4%, FY26 guidance of 2-6% growth

Heineken's FY25 top line and operating profit figures were slightly better than our forecasts with operating profit in absolute terms in line with consensus. Heineken guides again for sizeable savings efforts in FY26 with operating profit growth guidance calling for a 2-6% range (vs our and consensus forecasts of c. 5%). We still appreciate Heineken for the sizeable self-help initiatives which should support organic earnings growth in the coming years, but acknowledge that the bumpier volume evolution of the past few years makes the investment case a bit less predictable and hence also less ap...

9h / 12m 9h / 12m 1 EN

Mathijs Geerts Danau

Mathijs Geerts Danau

Pharvaris To present clinical data at the AAAAI 2026

Pharvaris will present multiple datasets at AAAAI 2026, including topline RAPIDe-3 results, final CHAPTER-1 data, supporting evidence for the extended-release formulation, AMRA endpoint validation, and results from a new kinin biomarker assay. We look forward to the prophylactic phase 3 (CHAPTER-3) readout in 3Q26 and reiterate our Buy and $ 36 TP.

9h / 32m 9h / 32m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Note: DSM NA

We are a financial services provider for several types of professional clients, each with distinct needs.

Benelux Morning Notes

DSM-Firmenich/Vitamin overdose/BUY

Benelux Morning Notes

Morning Notes : ABN NA, AD NA, HEIA NA, LOTB BB, RAND NA, ALFEN NA, PHVS US

Heineken FIRST LOOK: FY25 operating profit +4.4%, FY26 guidance of 2-6% growth

Pharvaris To present clinical data at the AAAAI 2026

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe